Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 261-280
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 LaToya Wilson Managing Director at Morgan Stanley | New York, United States | Corporate VCPrivate equity | FinTechHardware | View profile | |
 Sunny Reddy Principal at Aisling Capital | New York, United States | Venture capital | Healthcare | View profile | |
 Jason Kelly Founder at Ginkgo Bioworks | Cambridge, United States | Corporate VC | AIClimate | View profile | |
 Sachin Uppal Angel Investor at LVX | Bengaluru, India | Syndicate / Angel groupVenture capital | HealthcareSaaS | View profile | |
 James K. Venture Investor at New Enterprise Associates (NEA) | San Francisco, United States | Venture capital | AICommerce | View profile | |
 Martin Majlund Investor at American Chemical Society | Princeton, United States | Government-backed | ClimateEducation | View profile | |
 Brooke Seawell Board of Directors / Audit Committee Chair at NVIDIA | Menlo Park, United States | Corporate VCVenture capital | AICommerce | View profile | |
 Helga Mikkelsen Investment Manager at Brandon Capital | Perth, Australia | Venture capital | Healthcare | View profile | |
 Sarah Hymowitz Partner at The Column Group | San Francisco, United States | Venture capital | Healthcare | View profile | |
 Ron Bernal Venture Advisor at New Enterprise Associates (NEA) | Longmont, United States | Venture capital | AICommerce | View profile | |
 Elizabeth Hamrick Executive Director at Morgan Stanley | New York, United States | Corporate VCPrivate equity | FinTechHardware | View profile | |
 Jared Teo Managing Director at Healthquest Capital | San Francisco, United States | Private equityVenture capital | AIHealthcare | View profile | |
 Ignacio Puig Masllorens General Partner at Inveready | Barcelona, Spain | Private equityVenture capital | AICommerce | View profile | |
 Zara Asgharpour Investor at Lonza | Basel, Switzerland | Corporate VC | Healthcare | View profile | |
 Pierre Paffenhoff Climate Tech Venture Capital - Investment Director at Fonds de solidarité FTQ | Montreal, Canada | Private equityVenture capital | AIClimate | View profile | |
 Emil Willemoes Helms LD Fonde at Ld Pensions | Copenhagen, Denmark | Family Office | Healthcare | View profile | |
 Falon Donohue Affiliated at Narya Capital | United States | Venture capital | FoodHealthcare | View profile | |
 Christopher Gagliardi Principal at Sanofi | Boston, United States | Corporate VC | AIHealthcare | View profile | |
 Francesc Dosrius Lleonart Associate Director at Sanofi | Spain | Corporate VC | AIHealthcare | View profile | |
 Avi Kometz Partner at Deerfield Management | New York, United States | Private equityVenture capital | AIHealthcare | View profile |
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal